Search Results - "Kwee, Jolie K"
-
1
Design, Synthesis, and Pharmacological Evaluation of Novel N‑Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Published in Journal of medicinal chemistry (28-01-2016)“…This manuscript describes a novel class of N-acylhydrazone (NAH) derivatives that act as histone deacetylase (HDAC) 6/8 dual inhibitors and were designed from…”
Get full text
Journal Article -
2
Ação de Sais de Cobre sobre a Xantina Desidrogenase na Carcinogênese Hepática de Ratas
Published in Revista Brasileira de Cancerologia (09-08-2023)“…Os autores estudaram a inibição da atividade de xantina desidrogenase (XD) do soro de ratas pelo acetado de cobre (AcCu). Verificaram também a relação entre a…”
Get full text
Journal Article -
3
Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice
Published in Leukemia research (01-04-2007)“…Abstract The expression and activity of P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP1) were analyzed in 178 leukemia samples…”
Get full text
Journal Article -
4
CPT-11-induced cell death in leukemic cells is not affected by the MDR phenotype
Published in Leukemia research (01-03-2003)“…CPT-11 is a topoisomerase I (Topo I) inhibitor which was initially described as active in multi-drug resistance (MDR) tumors. The MDR phenomenon is…”
Get full text
Journal Article -
5
Leishmania amazonensis infection is reduced in macrophages treated with guanine ribonucleosides
Published in Acta tropica (15-06-1998)Get full text
Journal Article -
6
Cell proliferation induced by 8-oxoguanosine and 8-methylguanosine, two adducts produced by free radical attack on ribonucleosides and RNA
Published in Chemico-biological interactions (06-11-1998)“…The ability of C8-substituted guanine (Gua) ribonucleosides to induce B cell proliferation has been well documented in the literature. These compounds are…”
Get full text
Journal Article -
7
High Catalase Activity: Another Possible Pathway for Imatinib-Resistant CML Patients
Published in Blood (16-11-2005)“…Imatinib (imatinib mesylate: Novartis Pharmaceuticals, Basel, Switzerland) is a well-known selective inhibitor of BCR-ABL tyrosine kinase activity, a hallmark…”
Get full text
Journal Article